Under Senate Bill, Medicare Can Negotiate Some Drug Prices, But Power to Lower Prices Still Limited
August 9, 2022
7,890
323
58
4.83%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Amy Goodman Episodes Around August 9, 2022
See what was published immediately before and after this episode.
3:19Now PlayingUnder Senate Bill, Medicare Can Negotiate Some Drug Prices, But Power to Lower Prices Still Limited
YouTube Description
as posted by the channelWhen the Inflation Reduction Act passed the Senate Sunday, Republicans successfully blocked a price cap on insulin. Robert Weissman, president of Public Citizen, says that despite its flaws, the bill is a win against the pharmaceutical industry’s exploitative profits. “They’re super worried that this is a break in the dam and that it will lead to more negotiation, once we, the American people, see plainly the cost savings that are available,” says Weissman.
Democracy Now! is an independent global news hour that airs on over 1,500 TV and radio stations Monday through Friday. Watch our livestream at Mondays to Fridays 89 a.m. ET.
Support independent media
Subscribe to our Daily Email Digest
#DemocracyNow
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.